DivAirCity Social Health Survey

NCT06274229 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-02-23

No results posted yet for this study

Summary

To reduce stress among urban residents, the consortium members of the European Council Horizon 2020 research program DivAirCity install different stress reducing, noise reducing and air quality improving means in the five cities of the consortium. This study measures physiological and psychological stress and health factors before and after the implementation of the project (at intervention sites) and compares the change (improvement) to the change in comparable places where no means were installed (control site).

Conditions

  • Psychological Stress
  • Psychological Well-Being
  • Pollution; Exposure

Interventions

OTHER

Air pollution and noise reducing installations

A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.

Sponsors & Collaborators

  • Universitat Politècnica de València

    collaborator OTHER
  • Universitatea din Bucuresti

    collaborator OTHER
  • University of Aarhus

    collaborator OTHER
  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

    collaborator OTHER_GOV
  • European Commission

    collaborator OTHER
  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Andreas Michalsen, Prof MD · Charite Universitaetsmedizin Berlin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06274229 on ClinicalTrials.gov